By contrast, BAFF overexpression in non-autoimmune mouse models of dyslipidaemia resulted in reduced atherosclerosis and likewise, anti-BAFF antibody treatment increased atherosclerosis [19, 20]. This evidence concerns the gene TNFSF13B and inherited lipid metabolism disorder.